Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
General Introduction | Jiangzhong Pharmaceutical Co., Ltd. (stock code: 600750. SH) achieved a backdoor listing through the restructuring of Jiangxi Dongfeng Pharmaceutical Co., Ltd. in 1999. In February 2019, after the strategic restructuring of China Resources Pharmaceutical, the actual controller of Jiangzhong Pharmaceutical was changed from Jiangxi Provincial State owned Assets Supervision and Administration Commission to China Resources Co., Ltd. The ultimate actual controller was the State owned Assets Supervision and Administration Commission of the State Council. The company always adheres to traditional Chinese medicine theory, relies on advanced manufacturing technology, and in the spirit of pursuing the ultimate, combines traditional Chinese medicine theory with modern scientific research technology, committed to manufacturing world-renowned Chinese medicine products. The company is mainly engaged in the research and development, production, and sales of drugs and major health products. It has well-known and well-known trademarks such as "Jiangzhong", "Chuyuan", "Yangjisheng", and "Sanghai". Its main products include stomach strengthening and digestion tablets, compound Caoshan lozenges, lactobacillus tablets, bifidobacterium triple live bacteria enteric coated capsules (Beifeida), multi-dimensional element tablets, Shenlingcao oral liquid, Chuyuan compound peptide nutritional drinks, probiotics, and compound fresh bamboo juice Bazhen Yimu Capsules, etc. |
Headquarter | Nanchang |
Establish Date | 9/18/1996 |
Listed Code | 600750.SH |
Listed Date | 9/23/1996 |
Chairman | Liu Weiquan. |
CEO | Xiao Wenbin. |
Website | www.jzjt.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial